首页 › 骨髓增生异常综合征 › 加利福尼亚州 › Orange
Orange CA 骨髓增生异常综合征临床试验
7项针对 骨髓增生异常综合征的研究正在 Orange及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
招募中2 期
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
招募中2 期
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
招募中1/2 期
- Children's Hospital of Orange County, Orange
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
招募中1 期
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
招募中1/2 期
- University of California, Irvine, Orange
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
招募中2/3 期
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Orange
其他城市的 骨髓增生异常综合征试验
- Houston, TX43 项研究
- Baldwin Park, CA26 项研究
- New York City, NY21 项研究
- Seattle, WA21 项研究
- Washington, DC20 项研究
- Tampa, FL19 项研究
- Boston, MA19 项研究
- Miami, FL17 项研究
- Durham, NC14 项研究
- Columbus, OH14 项研究
- St. Louis, MO13 项研究
- Atlanta, GA13 项研究
Orange的其他研究
- 非小细胞肺癌25 项研究
- 转移性癌症20 项研究
- 结直肠癌16 项研究
- 卵巢癌16 项研究
- 胰腺癌15 项研究
- 黑色素瘤14 项研究
- 肝癌（肝细胞癌）14 项研究
- 乳腺癌14 项研究
- 肺癌14 项研究
- 前列腺癌14 项研究
- 胃癌13 项研究
- 癌症（所有类型）13 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。